started · updated
Alcon reports third quarter revenue growth to $2.7 billion
Alcon, the US-Swiss eye care company, reported third quarter revenue of $2.72 billion, representing a 5 percent increase in constant currency. The company's adjusted earnings per share rose by 15 percent to $0.91, supported by $58 million in US government customs refunds, lower depreciation, and production efficiency gains.
Growth was driven by the Vision Care segment, which saw a 6 percent revenue increase to $1.24 billion, including an 8 percent rise in eye care products and a 5 percent rise in contact lenses. The Surgical segment grew by 4 percent to $1.48 billion, though sales of intraocular lenses declined by 2 percent due to increased competitive pressure in the United States.
Following these results, Alcon has narrowed its full-year guidance and expanded its cost-saving programs. While the company noted strong demand for new products, CEO David Endicott acknowledged competitive challenges in specific areas, particularly regarding implantable lenses.